ロード中...
Androgen Receptor Promotes Tamoxifen Agonist Activity by Activation of EGFR in ERα-Positive Breast Cancer
PURPOSE: Tamoxifen (Tam) resistance represents a significant clinical problem in estrogen receptor (ER) -positive breast cancer. We previously showed that decreased expression of Rho guanine nucleotide dissociation inhibitor (Rho GDI), a negative regulator of the Rho GTPase pathway, is associated wi...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749407/ https://ncbi.nlm.nih.gov/pubmed/26487496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3609-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|